Your search returned 3 results.

Results
	1.	Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. [electronic resource] by Vasilakakis, D M D'Haese, P C Lamberts, L V Lemoniatou, E Digenis, P N De Broe, M E Producer: 19920724 In: Kidney international vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. [electronic resource] by Couttenye, M M D'Haese, P C Van Hoof, V O Lemoniatou, E Goodman, W Verpooten, G A De Broe, M E Producer: 19961217 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 11 Availability: No items available. Save to lists Add to cart (remove)
	3.	Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload. [electronic resource] by D'Haese, P C Couttenye, M M Goodman, W G Lemoniatou, E Digenis, P Sotornik, I Fagalde, A Barsoum, R S Lamberts, L V De Broe, M E Producer: 19960404 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 10 Availability: No items available. Save to lists Add to cart (remove)

Refine your search